Seroquel Lawsuit Settlement
Written by Jack Taylor
AstraZeneca Plc agreed has agreed to pay $150 million to settle more Seroquel lawsuits. Earlier it had settled numerous lawsuits by paying hefty amount of money, but it did not prove fatal blow for AstraZeneca as it settled a large amount of lawsuit against it related to Seroquel lawsuits. These lawsuits blamed that its antipsychotic drug Seroquel could lead diabetes as a side effect of this drug. It had paid around $350 million to resolve Seroquel lawsuits.
Seroquel is an oral drug containing quetiapine as main active ingredient. It is used for treatment of Schizophrenia in adults or children older tha
13 years. It is also used for treatment of bipolar disorder or manic depression in children above 10 years and adults. It is also used with other antidepressant drugs. Doctors prescribe it for other purposes as well. It was introduced for treatment of Schizophrenia in the market in 1997.
The use of Seroquel has been associated with hyperglycemia and diabetes in patients using this drug. Many studies also revealed the same fact. Reports about its association with these side effects started coming in since this drug came into circulation. FDA too issued safety alerts and warnings related to this drug. AstraZeneca was also linked to controversy about paying kickbacks to doctors for off label promotion of Seroquel.
AstraZeneca would be paying $150 million to resolve around 6,000 cases alleging Seroquel for on set of diabetes in patients using it. The AstraZeneca Plc. Is second largest drug making company in U.K. this settlement would pay an average amount of about $25,000 each case involved in the settlement.
After getting a favorable verdict in first Seroquel lawsuit to go to trial in March 2010, the company decided to settle other Seroquel lawsuits out of court to get rid of litigation hassles and bad name. This settlement involved court-ordered mediation. There were around about 4,000 Seroquel claims left after this settlement.
It also paid $198 million to settle 17,500 suits, two-thirds of the 26,000 suits related to side effects of Seroquel filed in courts around the U.S. the settlement involved average pay out of about $11,000. The company won the first jury trial over Seroquel in March 2010.
Seroquel earned $4.9 billion in 2009 and $5.3 billion in 2010 for AstraZeneca. These settlement payouts had not affected the company much. It enjoyed a good sale and good share price in the market.
It also paid $520 million to settle a lawsuit filed by Department of justice. The lawsuit blamed AstraZeneca of improperly promoting its anti psychotic medicatio
Seroquel for off label uses. The Justice Department blamed AstraZeneca to market this drug for treatment of aggression, Alzheimer’s disease, anxiety, depression and post-traumatic stress disorder (PTSD). All these are off label uses of the drug.
The company has paid around $738 million to get rid of Seroquel lawsuits as of December 2010. The pay out of $520 million to Department of Justice, U.S. to resolve U.S. allegations of illegal marketing of Seroquel for unapproved uses were in addition to above said amount.
For More Information Visit: http://www.unsafedrugs.com/3079/seroquel-lawsuit-settlement
Article author
About the Author
About Author: Jack Taylor Powers Taylor LLP is a boutique litigation firm that represents people injured by unsafe drugs. The attorneys of Powers Taylor founded this firm to focus on client needs. We employ unique and creative litigation strategies to obtain decisive results for our clients.
Further reading
Further Reading
Article
Why Patients Should Research Before Choosing a Hospital: A Smarter Approach to Healthcare
September 3, 2026
Article
Signs It May Be Time to Consider Dermal Fillers in Cincinnati — and How to Choose the Right Treatment Partner
Dermal fillers can help restore facial volume, improve definition, and create subtle, natural-looking enhancements without surgery. For those considering dermal fillers in Cincinnati, choosing an experienced medical provider is essential. A thorough consultation can help determine the right treatment, products, and are
August 27, 2026
Article
Turn Extra Test Strips Into Cash: HMH Med Buyback Expands Nationwide Program
A Growing Challenge in Diabetes Care Across the country, millions of people living with diabetes rely on test strips and other supplies to monitor their health. These items are essential, but they often accumulate in households for various reasons. Sometimes prescriptions change, sometimes people switch to different brands, and sometimes supplies arrive in larger quantities than needed. What was once a lifeline can quickly become a drawer full of unused materials. The Problem
February 17, 2026
Article
Why Malpractice Insurance is Essential for Anesthesiologists: An Overview of Costs and Benefits
The role of an anesthesiologist is critical in modern medicine, serving as the guardian of patient safety during surgical procedures. With this immense responsibility comes the necessity of having robust malpractice insurance . For anesthesiologists, the implications of malpractice claims can be profound, making understanding the associated costs and benefits of malpractice insurance essential. Understanding Malpractice Insurance Malpractice insurance is a specific type of pr
February 7, 2025